KP

Kannasandra Pushpalatha

Active Director Director DIN 01683405
DIN 01683405 First appointment Aug 2006 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Aug 2006
Shareholding value •••• Premium profile

About Kannasandra Pushpalatha

Data last updated:

Kannasandra Pushpalatha is a Director at Vipragen Biosciences Private Limited (since 2014), Director at Glogene Bio Private Limited (since 2025) and Director at Cypa Therapeutics Private Limited (since 2022). The companies operate in Pharma, Research & Development and E-Commerce. The largest current company by reported revenue is Vipragen Biosciences Private Limited at ₹18.35 Cr (FY 2025). Earlier, Kannasandra Pushpalatha was a Director at Genei Laboratories Private Limited (2015–2020) and Director at Enzene Biosciences Limited (2006–2011).

DIN 01683405
Primary Designation Director
Industry Pharma
First Appointment 28 Aug 2006
Oldest Company Age 14 yrs
Largest company Vipragen Biosciences Private Limited · ₹18.35 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vipragen Biosciences Private Limited U73100KA2012PTC063955
Director01 Jul 20142012₹18.35 Cr (FY 2025)Active
Glogene Bio Private Limited U72100KA2025PTC200609
Director03 Apr 20252025Active
Cypa Therapeutics Private Limited U73100KA2022PTC162124
Director06 Jun 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Genei Laboratories Private Limited U24233KA2013PTC067508
Director10 Dec 20152013₹9.23 Cr (FY 2026)Active
Enzene Biosciences Limited U24232PN2006PLC165610
Director28 Aug 20062006₹385 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Glogene Bio Private Limited
Vipragen Biosciences Private Limited
Cypa Therapeutics Private Limited
Genei Laboratories Private Limited
Premium access

Shareholding and investment profile for Kannasandra Pushpalatha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kannasandra Pushpalatha

Kannasandra Pushpalatha currently holds 3 directorships: Vipragen Biosciences Private Limited (Director, since 01 Jul 2014, revenue ₹18.35 Cr (FY 2025)); Glogene Bio Private Limited (Director, since 03 Apr 2025); Cypa Therapeutics Private Limited (Director, since 06 Jun 2022).

Kannasandra Pushpalatha was first appointed on 28 Aug 2006 as Director at Enzene Biosciences Limited. The most recent appointment on record is 03 Apr 2025 at Glogene Bio Private Limited.

Kannasandra Pushpalatha held 2 earlier board appointments: Genei Laboratories Private Limited (Director, 10 Dec 2015 to 21 Nov 2020); Enzene Biosciences Limited (Director, 28 Aug 2006 to 01 Dec 2011).

The current boards of Kannasandra Pushpalatha's companies include Pallavur Viswanathan Harikrishnan (Vipragen Biosciences Private Limited), Patlapati Harsha Samaraditya (Vipragen Biosciences Private Limited), Siddamadappa Chandrashekaran (Vipragen Biosciences Private Limited), Umesh Devurkar (Vipragen Biosciences Private Limited), Yashas (Vipragen Biosciences Private Limited), Suman Vijay Ambati (Glogene Bio Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available